Contrasting Biosig Technologies (NASDAQ:STEX) & Anzu Special Acquisition Corp I (NASDAQ:ANZUW)

Biosig Technologies (NASDAQ:STEX) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both manufacturing companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Profitability

This table compares Biosig Technologies and Anzu Special Acquisition Corp I’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
Anzu Special Acquisition Corp I	N/A	N/A	N/A

Earnings and Valuation

This table compares Biosig Technologies and Anzu Special Acquisition Corp I”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40,000.00	3,556.92	-$462.77 million	($9.71)	-0.08
Anzu Special Acquisition Corp I	N/A	N/A	N/A	N/A	N/A

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Biosig Technologies.

Analyst Recommendations

This is a breakdown of current recommendations for Biosig Technologies and Anzu Special Acquisition Corp I, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1	0	1	0	2.00
Anzu Special Acquisition Corp I	0	0	0	0	0.00

Biosig Technologies presently has a consensus price target of $8.00, suggesting a potential upside of 922.23%. Given Biosig Technologies’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Biosig Technologies is more favorable than Anzu Special Acquisition Corp I.

Insider & Institutional Ownership

7.2% of Biosig Technologies shares are held by institutional investors. 52.7% of Biosig Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Biosig Technologies beats Anzu Special Acquisition Corp I on 6 of the 8 factors compared between the two stocks.

About Biosig Technologies

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company’s proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

About Anzu Special Acquisition Corp I

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.